As we move into the second half of the decade, AI – particularly science-aware AI – seems destined to transform biopharma R&D, super-powering scientists, shortening discovery timelines and accelerating scientific breakthroughs.
We’re not going to see AI technologies replace the work of skilled scientists and researchers, but we will witness more and more ways that technology can step up to become a viable scientific assistant, capable of enhancing decision-making, supporting experimentation, reducing the reliance on bench work and moving significant parts of the drug discovery process to in silico.
Over the past year, several developments have made advanced AI capabilities available for everyday use in biopharma R&D, integrating AI directly into the platforms scientists already use, enhancing workflows without adding complexity.
Check out the rest of the feature here
